Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| NADPH Oxidase 4 | 1 | 2018 | 11 | 0.74 | Why? |
| NADPH Oxidase 2 | 1 | 2018 | 58 | 0.71 | Why? |
| Vascular Remodeling | 1 | 2018 | 99 | 0.70 | Why? |
| Diastole | 1 | 2017 | 168 | 0.67 | Why? |
| Oxidoreductases | 1 | 2017 | 136 | 0.65 | Why? |
| Bed Occupancy | 1 | 2020 | 476 | 0.64 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2018 | 219 | 0.58 | Why? |
| Ventricular Remodeling | 1 | 2018 | 349 | 0.54 | Why? |
| Heart Failure | 9 | 2021 | 6638 | 0.53 | Why? |
| Ventricular Dysfunction, Left | 2 | 2019 | 993 | 0.49 | Why? |
| Endothelial Cells | 4 | 2018 | 2048 | 0.49 | Why? |
| Angiotensin II | 1 | 2018 | 601 | 0.47 | Why? |
| Ventricular Function, Left | 2 | 2018 | 1555 | 0.46 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2018 | 698 | 0.46 | Why? |
| Myocytes, Cardiac | 1 | 2018 | 804 | 0.44 | Why? |
| Coronary Vessels | 1 | 2018 | 914 | 0.42 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.39 | Why? |
| Thrombolytic Therapy | 1 | 2020 | 2218 | 0.36 | Why? |
| Echocardiography | 2 | 2021 | 3661 | 0.34 | Why? |
| ST Elevation Myocardial Infarction | 2 | 2021 | 3051 | 0.33 | Why? |
| Cardiomegaly | 2 | 2017 | 96 | 0.33 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.31 | Why? |
| Stroke Volume | 4 | 2021 | 2153 | 0.30 | Why? |
| NADPH Oxidases | 1 | 2005 | 80 | 0.29 | Why? |
| Heart Diseases | 2 | 2020 | 3503 | 0.27 | Why? |
| Mice, Inbred C57BL | 4 | 2018 | 5542 | 0.26 | Why? |
| Mice, Knockout | 2 | 2018 | 1815 | 0.24 | Why? |
| Cardiovascular Diseases | 4 | 2021 | 11497 | 0.23 | Why? |
| Anoctamins | 1 | 2021 | 22 | 0.23 | Why? |
| Transducers | 1 | 2020 | 65 | 0.21 | Why? |
| Echocardiography, Doppler, Color | 1 | 2020 | 114 | 0.20 | Why? |
| Cell Fusion | 1 | 2021 | 400 | 0.20 | Why? |
| Giant Cells | 1 | 2021 | 334 | 0.18 | Why? |
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2017 | 16 | 0.18 | Why? |
| Thapsigargin | 1 | 2017 | 20 | 0.18 | Why? |
| Ligation | 1 | 2018 | 84 | 0.18 | Why? |
| Calcitonin Gene-Related Peptide | 1 | 2017 | 52 | 0.17 | Why? |
| Cardiovascular Physiological Phenomena | 1 | 2017 | 70 | 0.17 | Why? |
| Models, Cardiovascular | 1 | 2018 | 153 | 0.17 | Why? |
| Adoptive Transfer | 1 | 2018 | 250 | 0.17 | Why? |
| Forkhead Transcription Factors | 1 | 2018 | 231 | 0.16 | Why? |
| Neovascularization, Physiologic | 1 | 2018 | 160 | 0.16 | Why? |
| Systole | 1 | 2017 | 252 | 0.16 | Why? |
| Diet, High-Fat | 1 | 2017 | 161 | 0.16 | Why? |
| Echocardiography, Transesophageal | 1 | 2020 | 447 | 0.16 | Why? |
| Physiology | 1 | 2017 | 62 | 0.16 | Why? |
| Pressure | 1 | 2017 | 289 | 0.15 | Why? |
| Capillaries | 1 | 2018 | 257 | 0.15 | Why? |
| Aorta, Thoracic | 1 | 2018 | 271 | 0.15 | Why? |
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 291 | 0.15 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.14 | Why? |
| Cardiotonic Agents | 1 | 2017 | 418 | 0.13 | Why? |
| Endothelium, Vascular | 1 | 2005 | 1751 | 0.13 | Why? |
| Blood Pressure Determination | 1 | 2017 | 450 | 0.13 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2018 | 604 | 0.13 | Why? |
| Hypertension | 3 | 2021 | 8895 | 0.12 | Why? |
| Myeloid Cells | 1 | 2017 | 808 | 0.12 | Why? |
| United Kingdom | 7 | 2021 | 18046 | 0.12 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.12 | Why? |
| Adipose Tissue | 1 | 2017 | 612 | 0.12 | Why? |
| Cardiovascular Agents | 1 | 2017 | 663 | 0.11 | Why? |
| Aortic Valve Stenosis | 1 | 2019 | 741 | 0.11 | Why? |
| NF-kappa B | 1 | 2018 | 1301 | 0.11 | Why? |
| Hospitalization | 6 | 2021 | 54280 | 0.11 | Why? |
| Transcatheter Aortic Valve Replacement | 1 | 2019 | 839 | 0.10 | Why? |
| Proteomics | 1 | 2021 | 2481 | 0.10 | Why? |
| Animals | 9 | 2021 | 78931 | 0.10 | Why? |
| Disease Models, Animal | 2 | 2018 | 10998 | 0.10 | Why? |
| Patient Positioning | 1 | 2020 | 1505 | 0.10 | Why? |
| London | 3 | 2020 | 2166 | 0.10 | Why? |
| Drug Evaluation, Preclinical | 1 | 2021 | 3347 | 0.09 | Why? |
| GATA6 Transcription Factor | 1 | 2007 | 1 | 0.09 | Why? |
| Chondrogenesis | 1 | 2007 | 19 | 0.09 | Why? |
| Prone Position | 1 | 2020 | 1861 | 0.09 | Why? |
| Heart Ventricles | 1 | 2017 | 1139 | 0.09 | Why? |
| Cartilage | 1 | 2007 | 27 | 0.09 | Why? |
| Vertebrates | 1 | 2007 | 127 | 0.08 | Why? |
| Critical Care | 2 | 2021 | 14081 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.08 | Why? |
| Myocardium | 1 | 2018 | 2323 | 0.08 | Why? |
| Signal Transduction | 2 | 2018 | 7207 | 0.08 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.08 | Why? |
| Blood | 1 | 2007 | 274 | 0.08 | Why? |
| Isoenzymes | 1 | 2005 | 127 | 0.07 | Why? |
| Male | 17 | 2021 | 367725 | 0.07 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.07 | Why? |
| Mice | 4 | 2018 | 21357 | 0.07 | Why? |
| Blood Vessels | 1 | 2007 | 228 | 0.07 | Why? |
| Periodicals as Topic | 1 | 2017 | 1492 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
| Percutaneous Coronary Intervention | 1 | 2020 | 3646 | 0.06 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2018 | 4545 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.06 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.06 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.06 | Why? |
| Aged | 11 | 2021 | 215776 | 0.06 | Why? |
| Chloride Channels | 1 | 2021 | 51 | 0.06 | Why? |
| Female | 13 | 2021 | 380317 | 0.06 | Why? |
| Biological Variation, Individual | 1 | 2021 | 66 | 0.06 | Why? |
| Stem Cells | 1 | 2007 | 595 | 0.05 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.05 | Why? |
| Calcium Signaling | 1 | 2021 | 133 | 0.05 | Why? |
| Prognosis | 5 | 2021 | 32490 | 0.05 | Why? |
| Molecular Structure | 1 | 2005 | 1539 | 0.05 | Why? |
| Serum Amyloid P-Component | 1 | 2021 | 193 | 0.05 | Why? |
| Antigens, Neoplasm | 1 | 2021 | 230 | 0.05 | Why? |
| Reactive Oxygen Species | 1 | 2005 | 1136 | 0.05 | Why? |
| Humans | 21 | 2021 | 930598 | 0.05 | Why? |
| Comorbidity | 5 | 2021 | 34796 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2021 | 8207 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.04 | Why? |
| Electronic Health Records | 2 | 2021 | 3492 | 0.04 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Disease Progression | 3 | 2021 | 13580 | 0.04 | Why? |
| Blood Flow Velocity | 1 | 2017 | 193 | 0.04 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.04 | Why? |
| Oxygen Consumption | 1 | 2021 | 711 | 0.04 | Why? |
| Predictive Value of Tests | 2 | 2021 | 9537 | 0.04 | Why? |
| Body Temperature | 1 | 2021 | 875 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.04 | Why? |
| Cardiology Service, Hospital | 1 | 2021 | 602 | 0.03 | Why? |
| Societies, Scientific | 1 | 2017 | 414 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Alveolar Epithelial Cells | 1 | 2021 | 1445 | 0.03 | Why? |
| Radiography | 1 | 2020 | 1576 | 0.03 | Why? |
| Biomarkers, Tumor | 1 | 2021 | 1314 | 0.03 | Why? |
| Coronary Artery Disease | 1 | 2007 | 2570 | 0.03 | Why? |
| Natriuretic Peptide, Brain | 1 | 2019 | 1215 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.03 | Why? |
| Heart Rate | 1 | 2021 | 1527 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2020 | 17020 | 0.03 | Why? |
| Feasibility Studies | 1 | 2020 | 3467 | 0.03 | Why? |
| Thorax | 1 | 2020 | 1873 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.03 | Why? |
| Diagnostic Tests, Routine | 1 | 2021 | 2643 | 0.02 | Why? |
| Equipment Design | 1 | 2020 | 3095 | 0.02 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Embryo, Mammalian | 1 | 2007 | 86 | 0.02 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.02 | Why? |
| HEK293 Cells | 1 | 2021 | 8394 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| State Medicine | 1 | 2021 | 2847 | 0.02 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.02 | Why? |
| Cell Count | 1 | 2007 | 228 | 0.02 | Why? |
| Multiple Organ Failure | 1 | 2017 | 1724 | 0.02 | Why? |
| In Situ Hybridization | 1 | 2007 | 390 | 0.02 | Why? |
| Anthropometry | 1 | 2007 | 233 | 0.02 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.02 | Why? |
| Cell Line | 1 | 2021 | 12040 | 0.02 | Why? |
| Cell Nucleus | 1 | 2007 | 399 | 0.02 | Why? |
| Transfection | 1 | 2007 | 864 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Receptors, G-Protein-Coupled | 1 | 2007 | 309 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Europe | 1 | 2021 | 12702 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2021 | 8495 | 0.02 | Why? |
| DNA Primers | 1 | 2007 | 1170 | 0.02 | Why? |
| RNA, Small Interfering | 1 | 2007 | 817 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.01 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.01 | Why? |
| Adult | 4 | 2021 | 244371 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Virus Replication | 1 | 2021 | 14331 | 0.01 | Why? |
| Regression Analysis | 1 | 2007 | 2484 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Multivariate Analysis | 1 | 2007 | 5440 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| United States | 1 | 2017 | 46150 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 13720 | 0.01 | Why? |
| Exercise | 1 | 2007 | 6771 | 0.00 | Why? |
Shah's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(185)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(207)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_